US · Healthcare

Immunovant Inc (IMVT)

Biotechnology

Immunovant Inc (IMVT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IMVT

P/E ratio

18.00

Immunovant Inc (IMVT) — FAQ

What is IMVT's P/E ratio?

The price-to-earnings (P/E) ratio for Immunovant Inc (IMVT) is 18.00 (data as of 2026-03-24).

Does Immunovant Inc pay a dividend?

Dividend yield is not available in the current snapshot for Immunovant Inc (IMVT). Check the MyAverix Finance app for the latest dividend data.

What sector is Immunovant Inc in?

Immunovant Inc (IMVT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is IMVT listed on?

IMVT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)